Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration (Q82323360)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

Takako Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Koh-Hei Sonoda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kuniaki Hijioka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Takeshi Fujimoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tatsuro Ishibashi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

Japanese Journal of Ophthalmology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

502-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052918%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10384-010-0859-0

15 January 2020

exact match

0 references

cites work

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study

1 reference

12 December 2020